Binjie Yan

Education

Sept 2018-Present Ph.D. student in Basic Medicine, Hengyang Medical College, the University of South China

Jul 2015-Jul, 2018, Master's Degree in Medical Oncology, The University of South China

Sept 2010-Jul 2015, Bachelor's Degree in Clinical Medicine, The University of South China

Scholarship awards

China Scholarship Council (CSC)

Publications

1. ZeFan Wu, BinJie Yan, Wen Luo, DanDan Gui, Zhong Ren, Yun Ma, ZhiSheng Jiang. (2022). Ferroptosis and hydrogen sulfide in cardiovascular disease. Current Medicinal Chemistry. DOI:10.2174/0929867329666220630144648 (In Press)

2. Binjie Yan, Yanan Guo, Yu Gui, Zhi-Sheng Jiang and Xi-Long Zheng. (2021). Multifunctional RNase MCPIP1 and its Role in Cardiovascular Diseases. Current Medicinal Chemistry. 28(17): 3385-3405. DOI: 10.2174/0929867327999201113100918

3. Kun Zhou, KaiJiang Tian, BinJie Yan, DanDan Gui, Wen Luo, Zhong Ren, DangHeng Wei, LuShan Liu and Zhi-Sheng Jiang. (2021). A promising field: regulating imbalance of EndMT in cardiovascular diseases. Cell Cycle. 20(15): 1477-1486.DOI: 10.1080/15384101.2021.1951939

4. Zhen Tian, BinJie Yan, Wen Luo, DanDan Gui, Kun Zhou, Kai-Jiang Tian, Yun Ma, ZhiXiang Zhou and ZhiSheng Jiang. (2021). Sestrin2 in atherosclerosis. Clinica Chimica Acta. 532(2021): 325-329. DOI: 10.1016/j.cca.2021.10.019

5. Yanan Guo, Binjie Yan, Yu Gui, Zhihan Tang, Shi Tai, Shenghua Zhou and Xi-Long Zheng. (2021). Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall. Journal of Cellular Physiology. 236(4): 2333-2351. DOI: 10.1002/jcp.30025

6. DanDan Gui, Wen Luo, BinJie Yan, Zhong Ren, ZhiHan Tang, LuShan Liu, JiFeng Zhang, and ZhiSheng Jiang. (2021). Effects of gut microbiota on atherosclerosis through hydrogen sulfide. European Journal of Pharmacology. 896(2021): 17916. DOI: 10.1016/j.ejphar.2021.173916

7. Yanan Guo, Binjie Yan, Shi Tai, Shenghua Zhou and Xi-Long Zheng. (2021). PCSK9: Associated with cardiac diseases and their risk factors? Archives of Biochemistry and Biophysics. 704(2021): 108717. DOI: 10.1016/j.abb.2020.108717

8. Yanan Guo, Zhihan Tang, Binjie Yan, Hao Yin, Shi Tai, Juan Peng, Yuting Cui, Yu Gui, Darrell Belke, Shenghua Zhou and Xi-Long Zheng. (2021). PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 42(1: 67–86): 67 - 86. DOI: 10.1161/ATVBAHA.121.316902

9. NianHua Deng, Wen Luo, DanDan Gui, BinJie Yan, Kun Zhou, KaiJiang Tian, Zhong Ren, WenHao Xiong and Zhi-Sheng Jiang. (2021). Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathy. Molecular and Cellular Biochemistry. 477(1): 255-265. DOI: 10.1007/s11010-021-04278-z

10. ZhiXiang Zhou, Zhong Ren, BinJie Yan, ShunLin Qu, ZhiHan Tang, DangHeng Wei, LuShan Liu, MinGui Fu, and Zhi-Sheng Jiang. (2021). The Role of Ubiquitin E3 Ligase in Atherosclerosis. Current Medicinal Chemistry. 28(1): 152-168. DOI: 10.2174/0929867327666200306124418

11. Wen Luo, DanDan Gui, BinJie Yan, Zhong Ren, LiJun Peng, DangHeng Wei, LuShan Liu, DaWei Zhang and ZhiSheng Jiang. (2020). Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases. Cardiovascular Drugs and Therapy. 34(2020): 113-121. DOI: 10.1007/s10557-019-06927-4

12. HouQin Yuan, YaMeng Hao, Zhong Ren, HongFeng Gu, FengTao Liu, BinJie Yan, ShunLin Qu, ZhiHan Tang, LuShan Liu, DaXing Chen, and ZhiSheng Jiang. (2019). Tissue factor pathway inhibitor in atherosclerosis. Clinica Chimica Acta. 491: 97-102. DOI: 10.1016/j.cca.2019.01.024

13. Binjie Yan, Fang Wu, Nong Yang, and Yongchang Zhang. (2018). Lung squamous carcinoma involving the lip and cheek. The Lancet Oncology. 19(12): E726. DOI: 10.1016/S1470-2045(18)30441-8

14. Chunhua Zhou*, Binjie Yan*, Liang Zeng, Yi Xiong, Li Liu, Nong Yang, and Yongchang Zhang. (2018). Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation. Journal of Thoracic Disease. 10(8): E605-E611. DOI: 10.21037/jtd.2018.07.97 *Co-First Author

Hobbies